Number of Shares
81,066.38
Current Holdings Value*
$15.60 Mil
% of Portfolio
43.54%
Total Estimate Gain
$-8.50 Mil
% of Total Estimate Gain
-21.17%

KPCB XV Associates, LLC's RAPT Therapeutics Inc Holding Summary

As of 2022-09-30, KPCB XV Associates, LLC held 81,066.38 shares of RAPT Therapeutics Inc(RAPT), totaling $15.60 Mil. This investment constitutes 43.54% of their stock portfolio, and KPCB XV Associates, LLC now holds 2.19% of the outstanding RAPT Therapeutics Inc(RAPT) stock.

The initial trade took place in 2021Q1. In addition, there have been 2 sales at an average price of $187.92 for 162,316.50 shares. Based on historical transaction data and RAPT's current price of $13.94, KPCB XV Associates, LLC's estimated gain on his RAPT holdings is $-8.50 Mil, reflecting a -21.17% gain to date.

KPCB XV Associates, LLC RAPT ($13.94) Holding Chart

KPCB XV Associates, LLC RAPT ($13.94) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1